Journal of Biosciences and Medicines

Volume 5, Issue 3 (March 2017)

ISSN Print: 2327-5081   ISSN Online: 2327-509X

Google-based Impact Factor: 0.51  Citations  

Construction of Enriched Resource for Primary Therapeutic Targets of Approved and Clinical Trial Drugs

HTML  XML Download Download as PDF (Size: 245KB)  PP. 1-6  
DOI: 10.4236/jbm.2017.53001    1,402 Downloads   2,065 Views  

ABSTRACT

An assessment of the efficacy targets of drugs that represent an opportunity for targeted therapy is fundamental to the development of post-genomic research strategies within the pharmaceutical industry. Identification and validation of efficacy target is an important process in drug discovery and development. Extensive drug discovery efforts have yielded many approved and candidate drugs. Although sever drug databases provide the drug and their corresponding targets, there is an insufficient coverage of the clinical trial drugs over the past decades. Here, we conduct a comprehensive survey for current clinical trial drugs, therapeutic targets. The analysis contents include: 1) collect clinical trial drugs from different sources, 2) By analysis of the literature, we summarize the criteria for assign therapeutic targets for each drug based on its indication. The knowledge of these drugs and their targets is useful not only for drug discovery and development of targeted therapy, but also for facilitating the discovery of systems pharmacology.

Share and Cite:

Yang, H. , Yu, C. , Li, Y. and Zhu, F. (2017) Construction of Enriched Resource for Primary Therapeutic Targets of Approved and Clinical Trial Drugs. Journal of Biosciences and Medicines, 5, 1-6. doi: 10.4236/jbm.2017.53001.

Cited by

No relevant information.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.